Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee

Clinical trial NCT07550231 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07550231
Sponsor: Addpharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoarthritis of the Knees

Start date: 2026-06-01
Primary completion: 2027-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.